Quantbot Technologies LP Buys 11,663 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Quantbot Technologies LP boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,294 shares of the exchange traded fund’s stock after purchasing an additional 11,663 shares during the quarter. Quantbot Technologies LP owned about 0.06% of SPDR S&P Biotech ETF worth $4,349,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Proficio Capital Partners LLC lifted its position in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares in the last quarter. Mirae Asset Securities USA Inc. raised its position in SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $55,529,000.

SPDR S&P Biotech ETF Trading Up 1.3 %

Shares of XBI opened at $87.13 on Friday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The firm has a fifty day simple moving average of $90.06 and a 200 day simple moving average of $94.86. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.